SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
| Website | http://www.splisense.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research |
| Keywords | Cystic Fibrosis Treatment, Biotechnology, Genetic Diseases, Gene Therapy, Novel Therapies, Pulmonary Drug Delivery, Drug Development, Rare Diseases, Molecular Medicine, Respiratory Diseases, Biotechnology Research, Biopharmaceutical, Pharmaceutical Research, Clinical Trials, Genetic Engineering, Precision Medicine, Therapeutics |
| Competitors | Meltwater, Hootsuite, Sprout Social, Inc., Talkwalker, NetBase Solutions, Inc., Mention, Crimson Hexagon, DataSift, Sysomos Expion, BuzzSumo +44 more (view full list) |
Looking for a particular Splisense employee's phone or email?
Splisense Questions
Gili Hart is the CEO of Splisense.
10 people are employed at Splisense.
Top Splisense Employees
-
Gili Hart
Chief Executive Officer at Splisense
Jerusalem District, Israel41 -
Oren Gez
CBO at Splisense
Israel34 -
Lital Friedman
VP Clinical and Regulatory Affairs at Splisense
Jerusalem District, Israel2 -
2
-
Sara abu Swai
Research Assistant at Splisense
Jerusalem District, Israel1 -
Tehilla Blinder
RnD researcher at Splisense
Jerusalem District, Israel2
Related Companies
G2Crowd Trusted
300K+
Plugin Users
